Form 8-K - Current report:
SEC Accession No. 0000950172-04-002114
Filing Date
2004-09-07
Accepted
2004-09-07 17:21:20
Documents
2
Period of Report
2004-09-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K chi420419.txt 8-K 5331
2 EXHIBIT 3.01 neo3_1.txt EX-3.(II) 69981
  Complete submission text file 0000950172-04-002114.txt   77137
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: 8-K | Act: 34 | File No.: 001-12493 | Film No.: 041019205
SIC: 2836 Biological Products, (No Diagnostic Substances)